At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
Ambu® AuraOnce™ Disposable Laryngeal Maskdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Laryngeal Mask Airway Facilitates a Safe and Smooth Emergence From Anesthesia in Patients Undergoing Craniotomy: A Prospective Randomized Controlled Study
In Brief
A clinical study evaluating Ambu® AuraOnce™ Disposable Laryngeal Mask for Complications, Pulmonary. Completed, enrolled 62 participants across 1 site.
Detailed Summary
Stabilizing hemodynamic and reducing pulmonary complications during extubation with switching endotracheal tube to laryngeal mask in craniotomies
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsComplications, Pulmonary
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartFeb 2022
First PostedFeb 2022
Primary CompletionSep 2022
TodayJul 2026
First PostedFeb 23, 2022
Enrollment StartFeb 15, 2022
Primary CompletionSep 9, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.4 years ago
Interventions
Ambu® AuraOnce™ Disposable Laryngeal Maskdevice
Switching endotracheal tube to laryngeal mask at sevoflurane 2.63-2.97%, Removing endotracheal tube when spontaneously generating tidal volume of \>4ml/kg, EtCO2\<45mmHg, Train of four ratio \>70-90%.